Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to assess and compare the
efficacy and safety of two dose levels of somatropin over a long period (till final height is
reached). This trial is an extension to trials GHRETARD/BDP/14/NL (a 2-year initial trial)
and GHRETARD/BPD/20/NL (a 2-year extension trial).